These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22682699)

  • 1. The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero.
    Laronda MM; Unno K; Butler LM; Kurita T
    Differentiation; 2012 Oct; 84(3):252-60. PubMed ID: 22682699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero.
    Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA
    Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
    Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
    Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of the adolescent girl exposed in utero to DES.
    Gerbie MV
    Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diethylstilbestrol induces vaginal adenosis by disrupting SMAD/RUNX1-mediated cell fate decision in the Müllerian duct epithelium.
    Laronda MM; Unno K; Ishi K; Serna VA; Butler LM; Mills AA; Orvis GD; Behringer RR; Deng C; Sinha S; Kurita T
    Dev Biol; 2013 Sep; 381(1):5-16. PubMed ID: 23830984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In utero exposure to DES. Evaluation and followup of 199 women.
    Fowler WC; Edelman DA
    Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.
    Camp EA; Prehn AW; Shen J; Herbst AL; Strohsnitter WC; Hobday CD; Robboy SJ; Adam E
    J Womens Health (Larchmt); 2015 Apr; 24(4):308-15. PubMed ID: 25768943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL
    J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of the genital tract following stilbestrol exposure in utero.
    Kurman RJ
    Recent Results Cancer Res; 1979; 66():161-74. PubMed ID: 373028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six years' experience with screening of a diethylstilbestrol-exposed population.
    Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
    Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of p63 in the diethylstilbestrol-induced cervicovaginal adenosis.
    Kurita T; Mills AA; Cunha GR
    Development; 2004 Apr; 131(7):1639-49. PubMed ID: 14998922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine exposure to diethylstilbestrol: long-term effects in humans.
    Swan SH
    APMIS; 2000 Dec; 108(12):793-804. PubMed ID: 11252812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DES exposure and the aging woman: mothers and daughters.
    Laitman CJ
    Curr Womens Health Rep; 2002 Oct; 2(5):390-3. PubMed ID: 12215312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer risk in women exposed to diethylstilbestrol in utero.
    Hatch EE; Palmer JR; Titus-Ernstoff L; Noller KL; Kaufman RH; Mittendorf R; Robboy SJ; Hyer M; Cowan CM; Adam E; Colton T; Hartge P; Hoover RN
    JAMA; 1998 Aug; 280(7):630-4. PubMed ID: 9718055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Findings in female offspring of women exposed in utero to diethylstilbestrol.
    Kaufman RH; Adam E
    Obstet Gynecol; 2002 Feb; 99(2):197-200. PubMed ID: 11814496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diethylstilbestrol (DES) update: recommendations for the identification and management of DES-exposed individuals.
    Hammes B; Laitman CJ
    J Midwifery Womens Health; 2003; 48(1):19-29. PubMed ID: 12589302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
    Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
    Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States).
    Hatch EE; Herbst AL; Hoover RN; Noller KL; Adam E; Kaufman RH; Palmer JR; Titus-Ernstoff L; Hyer M; Hartge P; Robboy SJ
    Cancer Causes Control; 2001 Nov; 12(9):837-45. PubMed ID: 11714112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
    Newbold RR; McLachlan JA
    Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.